Ahmed Bennis/X
Nov 27, 2025, 05:00
LAAO vs. Anticoagulants․ What Works Best in ESRD Patients with AF?
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared on X:
”Outcomes of Stroke Prevention Strategies in Patients With Atrial Fibrillation and End-Stage Renal Disease.
In propensity-matched cohorts of ESRD patients with AF, the composite outcome of stroke or SE, MB, and all-cause mortality was higher in those treated with apixaban or warfarin compared with those who underwent LAAO.”
Read more here.
Stay updated with Hemostasis Today.
-
Jun 2, 2026, 19:42Sékouba Sidimé: vWD vs Hemophilia A – The Classic USMLE Step 1 trap in Hematology
-
Jun 2, 2026, 19:41Bassem M. Mohammed: How Factor VIII Interacts To Procoagulant Membranes To Support Activation Of Blood Clotting
-
Jun 2, 2026, 19:28Looking Beyond Bleeding Control To Understand Inflammation In Hemophilic Arthropathy – CRH French Reference Center for Hemophilia Lyon
-
Jun 2, 2026, 19:27Francisco Chacón-Lozsán: Coma Is Not a Diagnosis – Final Pathway Of Brain Arousal And Awareness Failure
-
Jun 2, 2026, 19:26Panagiotis Papanagiotou: Recognizing CVST On T2 MRI
-
Jun 2, 2026, 17:56Coralie Delporte Gravouil: Scientific Program 2026 – Essentials of Hemostasis Now Available
-
Jun 2, 2026, 17:55Anna Rivera: Hemophilia Management – A Shift from Traditional IV Therapies to Novel Subcutaneous Agents
-
Jun 2, 2026, 17:53Zoya Surayya: My Thesis on Anticoagulation After Ischemic Stroke
-
Jun 2, 2026, 17:49Jeffrey Hall: A Pivotal Moment to Protect Rhode Island Wildlife from Anticoagulant Rodenticides